Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies
We use essential cookies for the site to work and, with your permission, Google Analytics cookies to understand how the site is used. You can change your choice at any time. Privacy and Cookie Policy.